TY - JOUR
KW - Analgesics, Opioid/administration & dosage/adverse effects
KW - Buprenorphine/administration & dosage/adverse effects
KW - Buprenorphine, Naloxone Drug Combination/administration & dosage/adverse effects
KW - Female
KW - Humans
KW - Methadone/administration & dosage/adverse effects
KW - Neonatal Abstinence Syndrome/drug therapy
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/diagnosis/drug therapy
KW - Peripartum Period
KW - Pregnancy
KW - Pregnancy Complications/diagnosis/drug therapy
KW - Treatment Outcome
AU - Aileen Pan
AU - Mark Zakowski
A1 - 
AB - Opioid abuse and dependence continues to rise in both the general population and pregnancy, with opioid overdose deaths having quadrupled in the last 15 years. Illicit drug use in last 30 days of pregnancy was over 4% with almost 0.6% documented maternal opiate use at time of birth. The management of the opioid-tolerant, buprenorphine-dependent or methadone-dependent patient in the peripartum period is reviewed. Options for treatment of opioid dependence, acute pain management, and perioperative multimodal analgesia are discussed. The effects of maternal management on neonatal abstinence syndrome are also reviewed.
AD - *Department Anesthesiology, Section of Obstetric Anesthesiology, Cedars-Sinai Medical Center daggerAnesthesiology, Adjunct, Charles Drew University of Medicine and Science, Los Angeles, California.
BT - Clinical obstetrics and gynecology
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 2
CY - United States
DO - 10.1097/GRF.0000000000000288
IS - 2
JF - Clinical obstetrics and gynecology
LA - eng
M1 - Journal Article
N2 - Opioid abuse and dependence continues to rise in both the general population and pregnancy, with opioid overdose deaths having quadrupled in the last 15 years. Illicit drug use in last 30 days of pregnancy was over 4% with almost 0.6% documented maternal opiate use at time of birth. The management of the opioid-tolerant, buprenorphine-dependent or methadone-dependent patient in the peripartum period is reviewed. Options for treatment of opioid dependence, acute pain management, and perioperative multimodal analgesia are discussed. The effects of maternal management on neonatal abstinence syndrome are also reviewed.
PP - United States
PY - 2017
SN - 1532-5520; 0009-9201
SP - 447
EP - 458
EP - 
T1 - Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient
T2 - Clinical obstetrics and gynecology
TI - Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 28426507
U3 - 10.1097/GRF.0000000000000288
VL - 60
VO - 1532-5520; 0009-9201
Y1 - 2017
Y2 - Jun
ER -